Drax Group (LON:DRX – Get Free Report) had its target price hoisted by equities research analysts at Jefferies Financial Group from GBX 750 to GBX 1,120 in a report released on Wednesday,Digital Look reports. The firm presently has a “buy” rating on the stock. Jefferies Financial Group’s price target would suggest a potential upside of 25.91% from the company’s current price.
Several other research firms have also recently commented on DRX. Royal Bank Of Canada reissued an “outperform” rating and issued a GBX 950 price target on shares of Drax Group in a report on Wednesday, November 5th. Citigroup raised Drax Group to a “buy” rating and raised their target price for the company from GBX 689 to GBX 850 in a report on Wednesday, December 3rd. Four investment analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of GBX 980.
Get Our Latest Stock Analysis on DRX
Drax Group Stock Performance
Drax Group Company Profile
Drax Group plc, together with its subsidiaries, engages in renewable power generation in the United Kingdom. It operates through three segments: Pellet Production, Generation, and Customers. The Pellet Production segment produces and sells biomass pellets. The Generation segment provides renewable, dispatchable power, and system support services to the electricity grid. The Customers segment supplies electricity and gas to non-domestic customers. The company owns and operates Drax Power Station located in Selby, North Yorkshire; Cruachan Power Station, a pumped storage hydro station, with an installed capacity of 440 megawatts (MW) located in Argyll and Bute; and Lanark and Galloway hydro-electric power stations with an installed capacity of 126 MW located in southwest Scotland.
Featured Articles
- Five stocks we like better than Drax Group
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- ALERT: Drop these 5 stocks before January 2026!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Market Panic: Trump Just Dropped a Bomb on Your Stocks
- YDES Could Be 2026’s Biotech Breakthrough
Receive News & Ratings for Drax Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Drax Group and related companies with MarketBeat.com's FREE daily email newsletter.
